article: 1 from 1  
Acta chirurgica iugoslavica
2010, vol. 57, iss. 2, pp. 31-35
article language: English
Professional Paper
doi:10.2298/ACI1002031P

What are the possible reasons for urethral PSA varieties after radical prostatectomy?
aUniverzitet u Beogradu, Medicinski fakultet, Klinički centar Srbije
bSerbian Academy of Sciences and Arts - SASA
cInstitute for Radiology, Clinical Center of Serbia, Belgrade
dInstitute for Medical Biochemistry, Clinical Center of Serbia, Belgrade

Abstract

Objective: To examine the possible reasons for great varieties in urethral prostate specific antigen (urPSA) levels, in patients after radical prostatectomy (RP). Materials and methods: In 46 patients with prostate cancer, PSA, urPSA, total testosterone, body-mass index (BMI) and the stage of androgenic alopecia (AGA) were determined. Forty-five patients underwent retropubic RP, while one underwent cystoprostatectomy with orthotopic bladder construction, due to bladder cancer. Results: Average patients age prior to surgery plus or minus standard deviation was 65.2+5.8 years. Average urPSA was 20.9+47.5 ng/ml (0.05 to 212 ng/ml, median 2.24 ng/ml). With urethral PSA cut-off of 2.0 ng/ml, two groups were formed: A (urPSA < 2.0 ng/ml) and B (urPSA = 2.0 ng/ml). Patients in the group A had significantly lower average AGA score, than the patients from the group B (2.4+1.3 vs. 4.4+2.2, p=0.0003). In addition, patients from the group A had significantly lower postoperative PSA (0.07+0.08 ng/ml vs. 0.14 + 0.06 ng/ml, p=0.0014). Conclusions: The patients with higher urPSA have higher AGA scores and higher postoperative PSA. This phenomenon is probably the consequence of higher local dihydrotestosterone activity in the scalp and PSA-secreting urethral glands.

Keywords

References

Bolduc, S., Lacombe, L., Naud, A., Gregoire, M., Fradet, Y., Tremblay, R.R. (2007) Urinary PSA: A potential useful marker when serum PSA is between 2. 5 ng/mL and 10 ng/mL. Can Urol Assoc J., Nov; 1(4), str. 377-81
Breul, J., Pickl, U., Schaff, J. (1997) Extraprostatic production of prostate specific antigen is under hormonal control. J Urol, 157(1): 212-3
Chen, W., Yang, C.C., Chen, G.Y., Wu, M.C., Sheu, H.M., Tzai, T.S. (2004) Patients with a large prostate show a higher prevalence of androgenetic alopecia. Arch Dermatol Res, Nov;296(6):245-9
Chen, W., Yang, C.C., Chen, G.Y., i dr. (2004) Patients with a large prostate show a higher prevalence of androgenetic alopecia. Arch Dermatol Res, Nov;296(6):245-9
Coffey, D.S. (2001) Similarities of prostate and breast cancer: Evolution, diet, and estrogens. Urology, 57(4 Suppl 1): 31-8
Cohen, R.J., Garrett, K., Golding, J.L., Thomas, R.B., Mcneal, J.E. (2002) Epithelial differentiation of the lower urinary tract with recognition of the minor prostatic glands. Hum Pathol, 33(9): 905-9
Dallob, A.L., Sadick, N.S., Unger, W., i dr. (1994) The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness. J Clin Endocrinol Metab, Sep, 79(3), str. 703-6
de Guise, S., Bisaillon, A., Séguin, B., Lagacé, A. (1994) The anatomy of the male genital system of the beluga whale, Delphinapterus leucas, with special reference to the penis. Anat Histol Embryol, 23(3): 207-16
Demark-Wahnefried, W., Lesko, S.M., Conaway, M.R., i dr. (1997) Serum androgens: Associations with prostate cancer risk and hair patterning. J Androl, Sep-oct., 18(5), str. 495-500
Denmark-Wahnefried, W., Schildkraut, J.M., Thompson, D., i dr. (2000) Early onset baldness and prostate cancer risk. Cancer Epidemiol Biomarkers Prev, mar, 9(3), str. 325-8
Heidenreich, A., Aus, G., Abbou, C.C., Bolla, M., Joniau, S., Matveev, V., Schmid, H.-P., Zattoni, F. (2007) Guidelines on prostate cancer. in: European Association of Urology Guidelines
Hillenbrand, M., Bastian, M., Steiner, M., Zingler, C., Muller, M., Wolff, J.M., Seiter, H., Schuff-Werner, P. (2000) Serum-to-urinary prostate-specific antigen ratio in patients with benign prostatic hyperplasia and prostate cancer. Anticancer Res, 20(6D): 4995-6
Hoffmann, R. (2002) Hormonal interaction and hair growth. Ann Dermatol Venereol, May; 129(5 Pt 2), str. 787-92
Irani, J., Millet, C., Levillain, P., Dore, B., Begon, F., Aubert, J. (1997) Serum-to-urinary prostate specific antigen ratio: Its impact in distinguishing prostate cancer when serum prostate specific antigen level is 4 to 10 ng./ml. J Urol, 157(1): 185-8
Iwakiri, J., Granbois, K., Wehner, N., Graves, H.C., Stamey, T. (1993) An analysis of urinary prostate specific antigen before and after radical prostatectomy: Evidence for secretion of prostate specific antigen by the periurethral glands. J Urol, 149(4): 783-6
Kabalin, J.N., Hornberger, J.C. (1991) Prostate-specific antigen is not excreted by human kidney or eliminated by routine hemodialysis. Urology, 37(4): 308-10
Kaleczyc, J., Majewski, M., Calka, J., Lakomy, M., i dr. (1993) Adrenergic innervation of the epididymis, vas deferens, accessory genital glands and urethra in the boar. Folia Histochem Cytobiol, 31(3): 117-23
Kaufman, K.D. (2002) Androgens and alopecia. Mol Cell Endocrinol, Dec 30;198(1-2):89-95
Knussmann, R., Christiansen, K., Kannmacher, J. (1992) Relations between sex hormone level and characters of hair and skin in healthy young men. Am J Phys Anthropol, May;88(1), str. 59-67
Marks, L.S. (2004) 5alpha-reductase: history and clinical importance. Reviews in urology, 6 Suppl 9: S11-21
Nicaise, M., Lauwers, H., Simoens, P. (1991) Morphological study of the development of the disseminate prostate in intact and castrated male pigs aged two to six months. Acta Anat (Basel), 141(4): 335-47
Obiezu, C.V., Giltay, E.J., Magklara, A., Scorilas, A., Gooren, L.J., Yu, H., Howarth, D.J., Diamandis, E.P. (2000) Serum and urinary prostate-specific antigen and urinary human glandular kallikrein concentrations are significantly increased after testosterone administration in female-to-male transsexuals. Clin Chem, 46(6 Pt 1): 859-62
Oesterling, J.E., Tekchandani, A.H., Martin, S.K., Bergstralh, E.J., Reichstein, E., Diamandis, E.P., Yemoto, C., Stamey, T.A. (1996) The periurethral glands do not significantly influence the serum prostate specific antigen concentration. J Urol, 155(5): 1658-60
Oh, B.R., Kim, S.J., Moon, J.D., Kim, H.N., i dr. (1998) Association of benign prostatic hyperplasia with male pattern baldness. Urology, May; 51(5), str. 744-8
Olefsky, J.M. (1987) Obesity. in: Braunwald E. (ed.) Harrison's Principles of Internal Medicine, Hamburg: McGraw-Hill, ed. 11, vol 2, pp 1671-1676
Pannek, J., Rittenhouse, H.G., Evans, C.L., Finlay, J.A., Bruzek, D.J., Cox, J.L., Chan, D.W., Subong, E.N., Partin, A.W. (1997) Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer. Urology, 50(5): 715-21
Pejčić, T., Hadži-Đokić, J., Aćimović, M., Topuzović, C., Milković, B., Janjić, A. (2005) Urinary prostate specific antigen: Is the clinical use likely?. Acta chirurgica iugoslavica, vol. 52, br. 4, str. 69-74
Petros, J.A., Andriole, G.L. (1993) Serum PSA after antiandrogen therapy. Urol Clin North Am, 20(4): 749-56
Rittmaster, R., Hahn, R.G., Ray, P., i dr. (2008) Effect of dutasteride on intraprostatic androgen levels in men with benign prostatic hyperplasia or prostate cancer. Urology, Oct; 72(4), str. 808-12
Shibata, K., Kajihara, J., Kato, K., Hirano, K. (1997) Purification and characterization of prostate specific antigen from human urine. Biochim Biophys Acta, 1336(3): 425-33
Takayama, T.K., Vessella, R.L., Brawer, M.K., True, L.D., Noteboom, J., Lange, P.H. (1994) Urinary prostate specific antigen levels after radical prostatectomy. J Urol, 151(1): 82-7
Zaviacic, M., Ruzicková, M., Jakubovský, J., Danihel, L., Babál, P., Blazeková, J. (1994) The significance of prostate markers in the orthology of the female prostate. Bratislavské lekárske listy, 95(11): 491-7
Zhu, Y.S., Cai, L.Q., You, X., Cordero, J.J., Huang, Y., Imperato-Mcginley, J. (2003) Androgen-induced prostate-specific antigen gene expression is mediated via dihydrotestosterone in LNCaP cells. J Androl, Sep-oct; 24(5), str. 681-7